Market Summary
USD7.11-0.04
Market Closed-0.56%
VMD Stock Price
VMD RSI Chart
VMD Valuation
VMD Price/Sales (Trailing)
VMD Profitability
VMD Fundamentals
VMD Revenue
VMD Earnings
Price Action
52 Week Range
5.4612.01
(Low)(High)
Last 7 days
-0.6%
Last 30 days
-11.2%
Last 90 days
-25.5%
Trailing 12 Months
22.0%
VMD Financial Health
VMD Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for VMD
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-08-22 | Kaushal Nitin | acquired | - | - | 13,600 | - |
2023-08-22 | Smokoff Timothy | acquired | - | - | 13,600 | - |
2023-08-22 | Frazier William | sold (taxes) | -33,493 | 8.1 | -4,135 | chief medical officer |
2023-08-22 | Dobbs Randy E. | acquired | - | - | 16,000 | - |
2023-08-22 | Frazier William | acquired | - | - | 13,600 | chief medical officer |
2023-08-22 | Greenstein Bruce D | acquired | - | - | 13,600 | - |
2023-08-22 | Heltz Sabrina | acquired | - | - | 13,600 | - |
2023-08-14 | Hoyt Casey | gifted | - | - | 2,010,940 | chief executive officer |
2023-08-14 | Moore Michael | gifted | - | - | -1,722,610 | president |
2023-08-14 | Moore Michael | gifted | - | - | 1,722,610 | president |
Which funds bought or sold VMD recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | new | - | 1,976 | 1,976 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 30.77 | 60,439 | 368,428 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | new | - | 111,062 | 111,062 | -% |
2023-08-18 | Legato Capital Management LLC | added | 36.29 | 278,922 | 1,013,180 | 0.14% |
2023-08-15 | WELLS FARGO & COMPANY/MN | added | 1,246 | 126,876 | 136,920 | -% |
2023-08-15 | GOLDMAN SACHS GROUP INC | reduced | -20.85 | -582,252 | 2,348,020 | -% |
2023-08-14 | Forager Capital Management, LLC | reduced | -3.22 | 4,676,410 | 25,099,400 | 8.37% |
2023-08-14 | FEDERATED HERMES, INC. | added | 492 | 5,892 | 7,071 | -% |
2023-08-14 | Qube Research & Technologies Ltd | sold off | -100 | -775,611 | - | -% |
2023-08-14 | VANGUARD GROUP INC | added | 18.7 | 1,879,520 | 11,196,900 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of VIEMED HEALTHCARE
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| May 18, 2023 | moore michael | 6.3% | 2,421,319 | SC 13D/A | |
| Feb 21, 2023 | viemed healthcare, inc. | 7.6% | 2,973,243 | SC 13G/A | |
| Feb 08, 2023 | thrivent financial for lutherans | 10.88% | 4,134,751 | SC 13G/A | |
| Oct 18, 2022 | thrivent financial for lutherans | 10.1% | 3,855,125 | SC 13G/A | |
| Jul 08, 2022 | blackrock inc. | 2.4% | 967,193 | SC 13G | |
| Jun 28, 2022 | cove street capital, llc | 3.78% | 1,472,242 | SC 13G/A | |
| Mar 14, 2022 | cove street capital, llc | 5.06% | 2,006,944 | SC 13G | |
| Feb 17, 2022 | hoyt casey | 6.9% | 2,781,607 | SC 13G/A | |
| Feb 14, 2022 | thrivent financial for lutherans | 9.16% | 3,628,353 | SC 13G | |
| Feb 03, 2022 | blackrock inc. | 5.7% | 2,261,534 | SC 13G/A |
Recent SEC filings of VIEMED HEALTHCARE
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 06, 2023 | EFFECT | EFFECT | |
| Aug 28, 2023 | 4 | Insider Trading | |
| Aug 28, 2023 | 4 | Insider Trading | |
| Aug 28, 2023 | 4 | Insider Trading | |
| Aug 28, 2023 | 4 | Insider Trading | |
| Aug 28, 2023 | 4 | Insider Trading | |
| Aug 28, 2023 | 4 | Insider Trading | |
| Aug 24, 2023 | 4 | Insider Trading | |
| Aug 24, 2023 | 4 | Insider Trading | |
| Aug 24, 2023 | 4 | Insider Trading |
VMD Fair Value
Loading...
Peers (Alternatives to VIEMED HEALTHCARE)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
HCA | 69.4B | 61.9B | -7.50% | 26.00% | 12.02 | 1.12 | 3.02% | -11.37% |
LH | 18.2B | 14.1B | -4.84% | -6.54% | 21.91 | 1.29 | -5.68% | -58.27% |
DGX | 14.0B | 9.5B | -5.93% | 1.08% | 17.63 | 1.48 | -10.34% | -46.50% |
| MID-CAP | ||||||||
DVA | 9.4B | 11.7B | 1.41% | 13.03% | 20.16 | 0.8 | 0.96% | -43.93% |
ACHC | 6.5B | 2.8B | -6.23% | -13.68% | 23.9 | 2.33 | 13.40% | -2.45% |
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
PGNY | 3.3B | 957.5M | -8.01% | -15.46% | 66.71 | 3.43 | 55.17% | 8.05% |
GH | 3.2B | 510.2M | -27.36% | -50.73% | -6.35 | 6.32 | 25.00% | 4.56% |
AMN | 3.2B | 4.4B | -5.70% | -21.20% | 10.02 | 0.73 | -16.06% | -30.43% |
AMED | 3.1B | 2.2B | 1.82% | -17.96% | 1.3K | 1.38 | 0.61% | -98.34% |
| SMALL-CAP | ||||||||
RDNT | 1.9B | 1.5B | -8.12% | 43.46% | -147.16 | 1.24 | 12.20% | -155.34% |
ADUS | 1.4B | 999.1M | -7.68% | -7.58% | 25.63 | 1.38 | 10.42% | 21.37% |
VMD | 274.6M | 156.1M | -11.18% | 22.01% | 37.41 | 1.76 | 23.12% | -14.70% |
VIEMED HEALTHCARE News
Returns for VMD
Cumulative Returns on VMD
32.9%
5-Year Cumulative Returns
-8.9%
3-Year Cumulative Returns
Risks for VMD
What is the probability of a big loss on VMD?
92.3%
Probability that VIEMED HEALTHCARE stock will be more than 20% underwater in next one year
69.1%
Probability that VIEMED HEALTHCARE stock will be more than 30% underwater in next one year.
47.6%
Probability that VIEMED HEALTHCARE stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does VMD drawdown profile look like?
Y-axis is the maximum loss one would have experienced if VIEMED HEALTHCARE was unfortunately bought at previous high price.
Drawdowns
Financials for VIEMED HEALTHCARE
Income Statement (Last 12 Months)(In Thousands)
| Income Statement (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 6.8% | 156,134 | 146,133 | 138,832 | 133,286 | 126,812 | 120,901 | 117,062 | 116,302 | 120,464 | 135,919 | 131,309 | 121,555 | 108,476 | 85,947 | 80,256 | 77,171 | 73,733 | 68,616 | 64,464 | 61,468 | 58,342 |
| Gross Profit | 6.4% | 94,657 | 88,941 | 84,680 | 81,446 | 78,176 | 75,411 | 73,410 | 72,926 | 73,998 | 82,300 | 80,111 | 75,176 | 69,773 | 58,485 | 56,006 | 55,282 | 54,061 | 50,445 | 47,775 | 45,675 | 42,854 |
| S&GA Expenses | 4.2% | 75,174 | 72,147 | 68,161 | 65,229 | 60,812 | 56,160 | 54,893 | 52,927 | 53,217 | 56,761 | 52,829 | 50,729 | 47,410 | 42,498 | 41,381 | 40,903 | 40,134 | 36,505 | 34,304 | 32,811 | 30,292 |
| R&D Expenses | 3.0% | 2,930 | 2,844 | 2,696 | 2,586 | 2,492 | 2,403 | 2,110 | 1,893 | 1,560 | 1,248 | 1,083 | 891 | 856 | 788 | 848 | 645 | 437 | 234 | - | - | - |
| EBITDA | -100.0% | - | 25,703 | 24,851 | 25,096 | 25,529 | 25,949 | 24,166 | 24,099 | 24,475 | 23,905 | 26,922 | 24,266 | 23,136 | 12,096 | 9,129 | - | - | - | - | - | - |
| EBITDA Margin | -100.0% | - | 0.18* | 0.18* | 0.19* | 0.20* | 0.21* | 0.21* | 0.21* | 0.20* | 0.18* | 0.21* | 0.20* | 0.21* | 0.14* | 0.11* | - | - | - | - | - | - |
| Interest Expenses | 31.4% | 272 | 207 | 231 | 258 | 281 | 300 | 351 | 400 | 448 | 511 | 559 | 679 | 590 | 472 | 333 | 128 | 129 | 137 | 193 | 160 | 232 |
| Earnings Before Taxes | 19.6% | 10,171 | 8,501 | 8,990 | 10,461 | 12,125 | 13,549 | 12,503 | 12,670 | 13,440 | 23,394 | 26,363 | 23,587 | 22,546 | 11,130 | 8,796 | 9,445 | 8,795 | 9,543 | 9,670 | 8,767 | 8,642 |
| EBT Margin | -100.0% | - | 0.06* | 0.06* | 0.08* | 0.10* | 0.11* | 0.11* | 0.11* | 0.11* | 0.17* | 0.20* | 0.19* | 0.21* | 0.14* | 0.11* | - | - | - | - | - | - |
| Net Income | 22.8% | 7,340 | 5,977 | 6,222 | 7,871 | 8,605 | 9,204 | 9,126 | 10,110 | 11,125 | 28,971 | 31,530 | 28,847 | 28,896 | 10,810 | 8,525 | 9,105 | 8,471 | 9,243 | 9,508 | 8,720 | 8,642 |
| Net Income Margin | -100.0% | - | 0.04* | 0.04* | 0.06* | 0.07* | 0.08* | 0.08* | 0.09* | 0.09* | 0.21* | 0.24* | 0.24* | 0.27* | 0.13* | 0.11* | - | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 7,482 | 4,850 | 4,730 | 90.00 | 3,103 | 2,751 | 1,710 | 9,571 | 28,510 | 22,066 | 25,712 | 23,698 | 1,555 | 5,702 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 19.6% | 149 | 125 | 117 | 119 | 116 | 119 | 118 | 115 | 111 | 113 | 113 | 114 | 112 | 87.00 | 83.00 | 80.00 | 71.00 | 59.00 | 54.00 | 49.00 | 44.00 |
| Current Assets | -23.0% | 36.00 | 47.00 | 40.00 | 43.00 | 42.00 | 48.00 | 47.00 | 47.00 | 47.00 | 48.00 | 47.00 | 50.00 | 49.00 | 30.00 | 28.00 | 28.00 | 25.00 | 24.00 | 23.00 | 22.00 | 19.00 |
| Cash Equivalents | -56.6% | 10.00 | 24.00 | 17.00 | 21.00 | 22.00 | 29.00 | 28.00 | 27.00 | 31.00 | 31.00 | 31.00 | 32.00 | 30.00 | 8.00 | 13.00 | 13.00 | 8.00 | 7.00 | 10.00 | 10.00 | 9.00 |
| Inventory | 29.9% | 4.00 | 3.00 | 4.00 | 3.00 | 3.00 | 3.00 | 2.00 | 3.00 | 3.00 | 2.00 | 2.00 | 3.00 | 7.00 | 2.00 | 1.00 | 1.00 | 4.00 | 4.00 | 3.00 | 2.00 | 2.00 |
| Net PPE | 6.5% | 73.00 | 68.00 | 68.00 | - | - | 64.00 | 63.00 | 59.00 | 54.00 | 54.00 | 55.00 | 56.00 | 55.00 | 57.00 | 55.00 | 52.00 | 46.00 | 35.00 | 31.00 | 27.00 | 25.00 |
| Goodwill | - | 30.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Liabilities | 81.4% | 45.00 | 25.00 | 20.00 | 26.00 | 23.00 | 23.00 | 23.00 | 26.00 | 25.00 | 30.00 | 31.00 | 39.00 | 41.00 | 38.00 | 39.00 | 40.00 | 35.00 | 25.00 | 21.00 | 19.00 | 17.00 |
| Current Liabilities | 34.8% | 32.00 | 23.00 | 19.00 | 21.00 | 18.00 | 18.00 | 18.00 | 20.00 | 18.00 | 22.00 | 23.00 | 30.00 | 32.00 | 26.00 | 26.00 | 27.00 | 27.00 | 22.00 | 20.00 | 17.00 | 15.00 |
| LT Debt, Current | - | 3.00 | - | - | 0.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 0.00 | - | - | - | - |
| LT Debt, Non Current | - | 12.00 | - | - | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 5.00 | 6.00 | 6.00 | 7.00 | 7.00 | 8.00 | 8.00 | 5.00 | - | - | - | - |
| Shareholder's Equity | 4.5% | 105 | 100 | 97.00 | 94.00 | 93.00 | 96.00 | 95.00 | 89.00 | 86.00 | 83.00 | 82.00 | 75.00 | 71.00 | 49.00 | 44.00 | 40.00 | 36.00 | 34.00 | 33.00 | 30.00 | 27.00 |
| Retained Earnings | 3.3% | 73.00 | 71.00 | 70.00 | 68.00 | 69.00 | 73.00 | 73.00 | 69.00 | 67.00 | 66.00 | 66.00 | 61.00 | 58.00 | 38.00 | 34.00 | 32.00 | 29.00 | 28.00 | 27.00 | 26.00 | 24.00 |
| Additional Paid-In Capital | 11.6% | 13.00 | 12.00 | 12.00 | 11.00 | 10.00 | 9.00 | 8.00 | 7.00 | 5.00 | 4.00 | 7.00 | 6.00 | 5.00 | 4.00 | 6.00 | 5.00 | 5.00 | 4.00 | 5.00 | 5.00 | 4.00 |
| Shares Outstanding | 0.3% | 38.00 | 38.00 | 38.00 | 38.00 | 39.00 | 40.00 | 40.00 | 40.00 | 40.00 | 39.00 | 39.00 | 39.00 | 39.00 | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | 8.6% | 34.00 | 31.00 | 28.00 | 29.00 | 26.00 | 25.00 | 22.00 | 20.00 | 22.00 | 39.00 | 35.00 | 37.00 | 35.00 | 19.00 | 19.00 | 20.00 | 19.00 | 19.00 | 22.00 | 21.00 | 18.00 |
| Share Based Compensation | 3.8% | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 |
| Cashflow From Investing | -106.0% | -49.59 | -24.07 | -23.98 | -23.16 | -25.48 | -21.85 | -19.75 | -18.55 | -12.55 | -8.40 | -8.41 | -5.63 | -5.94 | -14.43 | -12.81 | -12.44 | -11.01 | -4.82 | -5.30 | -5.24 | -3.56 |
| Cashflow From Financing | 132.4% | 4.00 | -12.73 | -15.27 | -10.95 | -9.52 | -5.01 | -5.32 | -6.61 | -7.94 | -8.04 | -9.07 | -11.33 | -7.15 | -3.61 | -3.33 | -4.99 | -9.18 | -15.39 | -11.75 | -8.91 | -7.54 |
| Buy Backs | -66.6% | 3.00 | 8.00 | 10.00 | 9.00 | 7.00 | 0.00 | - | - | - | 1.00 | - | - | - | - | 2.00 | 3.00 | 3.00 | 4.00 | 2.00 | - | - |
VMD Income Statement
2023-06-30CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Revenue | $ 43,311 | $ 33,310 | $ 82,867 | $ 65,565 |
| Cost of revenue | 17,205 | 12,920 | 32,757 | 25,432 |
| Gross profit | 26,106 | 20,390 | 50,110 | 40,133 |
| Operating expenses | ||||
| Selling, general and administrative | 20,563 | 17,536 | 40,325 | 33,312 |
| Research and development | 758 | 672 | 1,538 | 1,304 |
| Stock-based compensation | 1,471 | 1,271 | 2,862 | 2,576 |
| Depreciation | 298 | 243 | 538 | 480 |
| Loss (gain) on disposal of property and equipment | 117 | (110) | 95 | (124) |
| Other (income) expense, net | (2) | (223) | (83) | (664) |
| Income from operations | 2,901 | 1,001 | 4,835 | 3,249 |
| Non-operating income and expenses | ||||
| Income from equity method investments | 137 | 446 | 172 | 769 |
| Interest income (expense), net | 20 | (59) | 69 | (123) |
| Net income before taxes | 3,058 | 1,388 | 5,076 | 3,895 |
| Provision for income taxes | 728 | 421 | 1,229 | 1,166 |
| Net income | 2,330 | 967 | 3,847 | 2,729 |
| Other comprehensive income (loss) | ||||
| Change in unrealized gain/loss on derivative instruments, net of tax | 0 | 59 | 0 | 222 |
| Other comprehensive income (loss) | 0 | 59 | 0 | 222 |
| Comprehensive income | $ 2,330 | $ 1,026 | $ 3,847 | $ 2,951 |
| Net income per share | ||||
| Basic (in dollars per share) | $ 0.06 | $ 0.02 | $ 0.10 | $ 0.07 |
| Diluted (in dollars per share) | $ 0.06 | $ 0.02 | $ 0.10 | $ 0.07 |
| Weighted average number of common shares outstanding: | ||||
| Basic (in shares) | 38,324,249 | 38,773,580 | 38,240,902 | 39,195,317 |
| Diluted (in shares) | 40,676,951 | 39,752,928 | 40,383,616 | 40,056,953 |
VMD Balance Sheet
2023-06-30CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | $ 10,224 | $ 16,914 |
| Accounts receivable, net | 17,893 | 15,379 |
| Inventory | 4,476 | 3,574 |
| Income tax receivable | 1,029 | 26 |
| Prepaid expenses and other assets | 2,327 | 3,849 |
| Total current assets | 35,949 | 39,742 |
| Long-term assets | ||
| Property and equipment, net | 72,884 | 67,743 |
| Finance lease right-of-use assets | 538 | 0 |
| Operating lease right-of-use assets | 516 | 694 |
| Equity investments | 1,942 | 2,155 |
| Debt investment | 2,110 | 2,000 |
| Deferred tax asset | 3,844 | 3,119 |
| Identifiable intangibles, net | 688 | 0 |
| Goodwill | 29,759 | 0 |
| Other long-term assets | 887 | 1,590 |
| Total long-term assets | 113,168 | 77,301 |
| TOTAL ASSETS | 149,117 | 117,043 |
| Current liabilities | ||
| Trade payables | 6,167 | 2,650 |
| Deferred revenue | 5,960 | 4,624 |
| Accrued liabilities | 15,509 | 11,092 |
| Finance lease liabilities, current portion | 375 | 0 |
| Operating lease liabilities, current portion | 395 | 495 |
| Current debt | 3,169 | 0 |
| Total current liabilities | 31,575 | 18,861 |
| Long-term liabilities | ||
| Accrued liabilities | 637 | 889 |
| Finance lease liabilities, less current portion | 143 | 0 |
| Operating lease liabilities, less current portion | 143 | 199 |
| Long-term debt | 12,114 | 0 |
| Total long-term liabilities | 13,037 | 1,088 |
| TOTAL LIABILITIES | 44,612 | 19,949 |
| Commitments and Contingencies | 0 | 0 |
| SHAREHOLDERS' EQUITY | ||
| Common stock - No par value: unlimited authorized; 38,400,422 and 38,049,739 issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | 17,850 | 15,123 |
| Additional paid-in capital | 13,488 | 12,125 |
| Retained earnings | 73,167 | 69,846 |
| TOTAL SHAREHOLDERS' EQUITY | 104,505 | 97,094 |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ 149,117 | $ 117,043 |
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.